Citigroup’s HUMANIGEN, INC. HGEN Stock Holding History

Citigroup’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10	Closed	-$2	–	5889
2023 Q2	$2	Hold	10	–	–	﹤0.01%	5546
2023 Q1	$1	Hold	10	–	–	﹤0.01%	5446
2022 Q4	$1	Hold	10	–	–	﹤0.01%	5748
2022 Q3	$0	Sell	10 -4,376	-100%	-$2.35K	﹤0.01%	6525
2022 Q2	$8K	Buy	4,386 +1,040	+31%	+$2.33K	﹤0.01%	5472
2022 Q1	$10K	Sell	3,346 -10,311	-75%	-$27.6K	﹤0.01%	5564
2021 Q4	$51K	Sell	13,657 -272,566	-95%	-$1.59M	﹤0.01%	5060
2021 Q3	$1.7M	Buy	286,223 +98,273	+52%	+$1.38M	﹤0.01%	2672
2021 Q2	$3.27M	Sell	187,950 -84,502	-31%	-$1.54M	﹤0.01%	2269
2021 Q1	$5.2M	Buy	272,452 +253,184	+1,314%	+$4.62M	﹤0.01%	1759
2020 Q4	$337K	Buy	+19,268	New	+$231K	﹤0.01%	4561

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Citigroup's HGEN Position: Q3 2023 in Review

Citigroup sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 10 shares — an estimated $2 sold.

Citigroup first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $5.2M in Q1 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Citigroup reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Citigroup sold 10 HUMANIGEN, INC. shares in Q3 2023, an estimated $2.
Citigroup first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
Citigroup's HUMANIGEN, INC. position peaked at $5.2M in Q1 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.